First Quadrant’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-9,813
| Closed | -$23K | – | 909 |
|
|
2018
Q2 | $23K | Buy |
+9,813
| New | +$23K | ﹤0.01% | 741 |
|
|
2018
Q1 | – | Sell |
-16,267
| Closed | -$45K | – | 993 |
|
|
2017
Q4 | $45K | Buy |
16,267
+7,167
| +79% | +$19.8K | ﹤0.01% | 854 |
|
|
2017
Q3 | $31K | Buy |
+9,100
| New | +$31K | ﹤0.01% | 870 |
|
|
2017
Q1 | – | Sell |
-259,833
| Closed | -$551K | – | 885 |
|
|
2016
Q4 | $551K | Sell |
259,833
-142,113
| -35% | -$301K | 0.01% | 525 |
|
|
2016
Q3 | $1.35M | Buy |
401,946
+230,346
| +134% | +$772K | 0.03% | 398 |
|
|
2016
Q2 | $539K | Buy |
171,600
+151,900
| +771% | +$477K | 0.01% | 479 |
|
|
2016
Q1 | $66K | Buy |
+19,700
| New | +$66K | ﹤0.01% | 669 |
|
|
2015
Q4 | – | Sell |
-38,000
| Closed | -$191K | – | 886 |
|
|
2015
Q3 | $191K | Buy |
+38,000
| New | +$191K | ﹤0.01% | 547 |
|
|
2014
Q3 | – | Sell |
-67,700
| Closed | -$655K | – | 870 |
|
|
2014
Q2 | $655K | Sell |
67,700
-175,200
| -72% | -$1.7M | 0.01% | 440 |
|
|
2014
Q1 | $2.02M | Sell |
242,900
-10,200
| -4% | -$84.7K | 0.05% | 304 |
|
|
2013
Q4 | $2.14M | Hold |
253,100
| – | – | 0.05% | 311 |
|
|
2013
Q3 | $2.02M | Buy |
253,100
+8,800
| +4% | +$70.1K | 0.05% | 291 |
|
|
2013
Q2 | $1.89M | Buy |
+244,300
| New | +$1.89M | 0.05% | 293 |
|